Key result
Dual use of conventional and e-cigarettes linked to ~50% higher odds of metabolic syndrome.
Why the study?
Does dual use of e-cigarettes and conventional cigarettes or cigarette-only smoking increase the risk of metabolic syndrome compared to non-smoking in adults?
Cross-Sectional (n=4,942)
Does dual use of e-cigarettes and conventional cigarettes or cigarette-only smoking increase the risk of metabolic syndrome compared to non-smoking in adults?
Odds Ratio: 1.5 (95% CI 1.02–2.19)
p-value: p=0.038
Both dual use of e-cigarettes with conventional cigarettes and cigarette-only smoking are associated with higher odds of metabolic syndrome compared to non-smoking in Korean adults.
Introduction Despite the recent increase in the number of e-cigarette users, the association between smoking patterns involving e-cigarette use, particularly dual use with conventional cigarettes, and metabolic syndrome (MetS) remains poorly explored. This study examined the association of dual use and cigarette-only smoking with MetS relative to non-smoking. Methods This study involved 4,942 adults aged ≥19 years from the Korea National Health and Nutrition Examination Survey (2023). Participants were classified into non-smokers ( n = 4,156, 81.2%), cigarette-only smokers ( n = 625, 14.3%), and dual users ( n = 161, 4.4%), defined as current smokers of conventional cigarettes who concurrently use either heated tobacco products (HTPs) or liquid e-cigarettes. Multivariate logistic regression analysis was used to assess associations between smoking types and MetS. Results The odds of MetS were significantly higher in dual users (OR = 1.50, 95% CI = 1.02–2.19, p = 0.038) and cigarette-only smokers (OR = 1.41, 95% CI = 1.10–1.81, p = 0.008) than in non-smokers. Considering MetS components, the odds of hypertriglyceridemia was higher in dual users (OR = 2.16, 95%CI = 1.46–3.18, p < 0.001) and cigarette-only smokers (OR = 1.91, 95% CI = 1.54–2.36, p < 0.001) than in non-smokers; the odds of low high-density lipoprotein cholesterol levels was higher only in cigarette-only smokers (OR = 2.32, 95% CI = 1.78–3.02, p < 0.001). Conclusion Both dual users and cigarette-only smokers showed higher odds of MetS compared with non-smokers. Hypertriglyceridemia was associated with both smoking groups, whereas low HDL cholesterol was associated only with cigarette-only smokers. Public health strategies should continue to support smoking cessation and improve awareness regarding the potential metabolic risks associated with smoking behaviors.
No takes yet. Share an insight, caveat, or question.
Park et al. (2026) conducted a cross-sectional in Metabolic syndrome (n=4,942). Dual use of conventional cigarettes and e-cigarettes vs. Non-smoking was evaluated on Metabolic syndrome (OR 1.50, 95% CI 1.02-2.19, p=0.038). Dual use of conventional and e-cigarettes was associated with significantly higher odds of metabolic syndrome compared with non-smoking (OR 1.50; 95% CI 1.02-2.19; p=0.038).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: